The estimated Net Worth of Capital, Llc Boxer Asset Ma... is at least $0 dollars as of 24 October 2013. Capital Ma owns over 400,000 units of Sophiris Bio Inc stock worth over $0 and over the last 11 years Capital sold SPHS stock worth over $0.
Sign up
Capital Ma SPHS stock SEC Form 4 insiders trading
Capital has made over 2 trades of the Sophiris Bio Inc stock since 2013, according to the Form 4 filled with the SEC. Most recently Capital bought 400,000 units of SPHS stock worth $7,000,000 on 24 October 2013.
The largest trade Capital's ever made was buying 1,600,000 units of Sophiris Bio Inc stock on 16 August 2013 worth over $8,000,000. On average, Capital trades about 1,000,000 units every 35 days since 2013. As of 24 October 2013 Capital still owns at least 429,341 units of Sophiris Bio Inc stock.
You can see the complete history of Capital Ma stock trades at the bottom of the page.
Wallmine is a radically better financial terminal.
Sign up in seconds, it's free!
Wallmine is a radically better financial terminal.
Sign up in seconds, it's free!
Insiders trading at Sophiris Bio Inc
Over the last 11 years, insiders at Sophiris Bio Inc have traded over $592,052 worth of Sophiris Bio Inc stock and bought 1,642,180 units worth $8,144,540 . The most active insiders traders include Capital, Llc Boxer Asset Ma..., Capital, Llc Boxer Asset Ma..., and William R Rohn. On average, Sophiris Bio Inc executives and independent directors trade stock every 155 days with the average trade being worth of $0. The most recent stock trade was executed by Randall E Woods on 19 September 2018, trading 10,000 units of SPHS stock currently worth $26,300.
What does Sophiris Bio Inc's logo look like?
Complete history of Capital Ma stock trades at Mirati Therapeutics Inc and Sophiris Bio Inc
Sophiris Bio Inc executives and stock owners
Sophiris Bio Inc executives and other stock owners filed with the SEC include:
-
Randall Woods,
President, Chief Executive Officer, Director -
Allison Hulme,
Director -
Randall E. Woods,
Pres, CEO & Director -
Peter Slover,
Chief Financial Officer -
Lars Ekman,
Chairman of the Board -
Gerald Proehl,
Independent Director -
John Geltosky,
Independent Director -
Iain R. Mant Esq.,
Corp. Sec. -
Dr. James Joseph Beesley,
Sr. Director of Investor Relations -
Dr. Samuel R. Denmeade M.D.,
Chief Scientific Officer & Member of the Scientific Advisory Board -
James L Heppell,
Director -
Joseph L Turner,
Director -
Capital, Llc Boxer Asset Ma...,
-
William R Rohn,
Director -
Capital, Llc Boxer Asset Ma...,